Oliver Adunka, MD 08/01/2020 – 07/31/2025 NIH/NIDCD U01DC018920
Clinical Utility of Residual Hearing in the Cochlear Implant Ear

Lauren Bakaletz, PhD 09/30/1999 – 03/31/2026 NIH/NIDCD R01DC003915
Determinants of H. influenzae Virulence in Otitis Media

Tendy Chiang, MD 07/16/2021 – 06/30/2026 NIH/NHLBI R01HL157039
Tissue-Engineered Trachea Composites for Long-Segment Airway Replacement

Thomas Cherpes, MD, DVM 07/01/2021 – 05/31/2023 NIH/NIDCD R01HD094634
Estrogen Reverses Progestin-mediated Loss of Genital Mucosal Barrier Function

Shuman He, MD, PhD 04/01/2023 – 03/31/2028 NIH/NIDCD R21DC019458
Auditory Neural Function in Implanted Patients with Usher Syndrome

Shuman He, MD, PhD 03/01/2020 – 02/28/2025 NIH/NIDCD R01DC018044
Encoding Temporal Fine Structure for Cochlear Implants

Shuman He, MD, PhD 09/12/2019 – 08/31/2024 NIH/NIDCD R01DC018701
Music Appreciation after Cochlear Implantation

Shuman He, MD, PhD 04/01/2019 – 03/31/2024 NIH/NIDCD R01DC017846
Neural Encoding and Auditory Processing of Electrical Stimulation in Pediatric Cochlear Implant Users

Daniel Merfeld, PhD 09/01/2021 – 08/31/2026 NIH/NIA R01AG073113
Towards healthy aging: Quantifying vestibular contributors to age-related changes in balance and fall risk

Daniel Merfeld, PhD 09/12/2020 – 03/23/2023 NIH/NIBIB R01EB029818
Moving MRI: Imaging a Moving Body with a Moving MRI Magnet

Yin Ren, MD, PhD 01/01/2023 – 12/31/2027 NIH/NIDCD K08DC020761 
Engineering Protease Biomarkers to Guide Surgical Therapy for Vestibular Schwannoma and Neurofibromatosis Type 2

James Rocco, MD, PhD 03/28/2019 – 02/28/2025 NCI/NCTN UG1CA233331
OSU as a Network Lead Academic Participating Site for the NCI NCTN 

James Rocco, MD, PhD 07/18/2022 – 06/30/2027 NCI/NCTN R01CA265975 
Racial Differences in Immunogenetic Tumorigenesis of Head and Neck Squamous Cell Carcinoma

Andrew Wagner, MD 01/01/2023 – 12/31/2024 NIH/NIDCD K99ADC020759 
Investigating Subthreshold Vestibular Stimulation as a Strategy for Rehabilitation in Individuals with Bilateral Vestibular Hypofunction

Ruili Xie, PhD 07/01/2022 – 06/30/2027 NIH/NIDCD R01DC016037
Auditory Nerve Synaptopathy and the Central Mechanisms Underlying Noise-induced Hearing Loss

Ruili Xie, PhD 09/19/2017 – 06/30/2023 NIH/NIDCD R56DC019093
Cellular Mechanisms of Age Related Hearing Loss

Kai Zhao, PhD 09/26/2022 – 07/31/2027 NIH/NIDCD R01DC020302
Novel Mechanisms and Therapeutic Approaches for Nasal Obstruction and Olfactory Losses

Kai Zhao, PhD 02/01/2023-01/31/2028 NIH/NIDCD R01DC020737
Short-term and Long-term Impact of COVID-19 on Multiple Sensory Systems

Oliver Adunka, MD 08/15/2019 – 08/14/2023 DOD
Cochlear Synaptopathy Using Electrocochleography

Eugene Chio, MD 10/26/2022 – 10/26/2024 Inspire
The Predictor Study:  Assessing Diagnostic Predictors of Airway Collapse in Patients with Obstructive Sleep Apnea

Eugene Chio, MD 06/22/2018 – 06/21/2024 Inspire
Adherence and Outcome of Upper Airway Stimulation (UAS) for Obstructive Sleep Apnea (OSA) International Registry

Casey Curtis, MD 02/08/2020 – 02/17/2024 AstraZeneca
A Multicentre, Randomised, Double-blind, Parallel-group, Placebo controlled, 24-week Phase 3 Study with an Open-label Extension to Evaluate the Efficacy and Safety of Benralizumab in Patients with Hypereosinophilic Syndrome (HES)

Carrie Davenport, PhD 06/01/2022 – 05/31/2024 PCORI
Building Capacity for Engaging Families in Early Hearing Detection and Intervention Research

Vivian Kaul, MD 07/01/2022 – 06/30/2023 American Neurotology Society
Improving Patient Satisfaction and Quality of Life Outcomes for Cochlear Implant Patients through an Interactive Web and Mobile-Based Patient Education Platform

Daniel Merfeld, PhD 05/01/2023 – 04/30/2025 NAMRU-D
Vestibular Impacts on Human Behavior, Sleep, and Performance

Daniel Merfeld, PhD 05/01/2020 – 04/30/2025 Office of Naval Research
Identifying Adverse Modes via Human Machine Cybernetic Modeling

Daniel Merfeld, PhD 11/03/2022 – 01/17/2023 Soartech
Wing Instruction Spatial Disorientation Outcome Measure (WISDOM)

Daniel Merfeld, PhD 04/15/2019 – 04/14/2024 DOD
Evaluating a Portable Virtual-Reality (VR) Balance Test as a Vestibular Assessment Screen

Kyle VanKoevering, MD 10/13/2021 – 06/30/2023 NCI                        
Tissue Procurement Protocol for the Developmental Therapeutics Clinic

Casey Curtis, MD – Multicentre, Randomised, Double-blind, Parallel-group, Placebo-controlled, 24-week Phase 3 Study with an Open-label Extension to Evaluate the Efficacy and Safety of Benralizumab in Patients with Hypereosinophilic Syndrome (HES)

Casey Curtis, MD and Christopher Brooks, MD – A Randomized, Double-Blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Depemokimab in Adults with Hypereosinophilic Syndrome

Eugene Chio, MD – Adherence and Outcome of Upper Airway Stimulation (UAS) for Obstructive Sleep Apnea (OSA) International Registry

Eugene Chio, MD – Multicenter Study to Assess the Safety and Effectiveness of the Genio™ Dual-sided Hypoglossal Nerve Stimulation System for the Treatment of Obstructive Sleep Apnea in Adult Subjects

Eugene Chio, MD – The PREDICTOR Study: Assessing Diagnostic Predictors of Airway Collapse in Patients With Obstructive Sleep Apnea

Amit Agrawal, MD – Randomized Phase II/III Trial of Sentinel Lymph Node Biopsy versus Elective Neck Dissection for Early-Stage Oral Cavity Cancer

Sujith Baliga, MD – Randomized Phase II/III Trial of Radiation with High-Dose Cisplatin (100 MG/M2) Every Three Weeks Versus Radiation with Low-Dose Weekly Cisplatin (40 MG/M2) for Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Priyanka Bhateja, MD – A Phase II/III Randomized Study of Maintenance Nivolumab versus Observation in Patients with Locally Advanced, Intermediate Risk HPV Positive OPSCC

Priyanka Bhateja, MD – Phase I Trial with Expansion Cohort of DNA-PK Inhibition and IMRT in Cisplatin-Ineligible Patients with Stage 3-4 Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)

Priyanka Bhateja, MD – A Phase II, Open-Label, Multi-Center Study of PDS0101 (R-DOTAP [Versamune®] + HPVmix) and Pembrolizumab (KEYTRUDA®) Combination Immunotherapy in Subjects with Recurrent and/or Metastatic Head and Neck Cancer and High-Risk Human Papillomavirus-16 (HPV16) Infection

Priyanka Bhateja, MD – A Phase II Study of ALX148 in Combination with Pembrolizumab and Chemotherapy in Patients with Advanced Head and Neck Squamous Cell Carcinoma (Aspen-04)

Priyanka Bhateja, MD – A Phase II Study of ALX148 in Combination with Pembrolizumab in Patients with Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-03)

Dukagjin Blakaj, MD, PhD – Birinapant and Intensity Modulated Re-Irradiation Therapy (IMRRT) for Locoregionally Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC)

Dukagjin Blakaj, MD, PhD – HNSALV Trial: Combining Immunotherapy with Salvage Surgery and IORT for Treatment of Persistent/Recurrent Head and Neck Cancers      

Dukagjin Blakaj, MD, PhD – Randomized Phase II/III Trial of Surgery and Postoperative Radiation Delivered with Concurrent Cisplatin Versus Docetaxel Versus Docetaxel and Cetuximab for High-Risk Squamous Cell Cancer of The Head And Neck

Dukagjin Blakaj, MD, PhD – Keystroke: A Randomized Phase II Study of Pembrolizumab (Keytruda) Plus Stereotactic Re-Irradiation versus SBRT Alone for Locoregionally Recurrent or Second Primary Head and Neck Carcinoma

Marcelo Bonomi, MD – A Controlled, Randomized Phase II Trial of Docetaxel plus Trastuzumab versus Ado-Trastuzumab Emtansine for Recurrent, Metastatic, or Treatment-Naive, Unresectable HER-2 Positive Salivary Gland Cancer

Marcelo Bonomi, MD – A Phase II Trial of the Efficacy and Safety of the Combination of Cemiplimab and Low-dose Paclitaxel and Carboplatin in Patients with Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

Enver Ozer, MD – A Pilot Study Assessing Transoral Robotic Surgery (TORS) for Oral and Laryngopharyngeal Benign and Malignant Lesions Using the Da Vinci Robotic Surgical System

James Rocco, MD, PhD – Phase II Randomized Trial of Adjuvant Radiotherapy with or Without Cisplatin for p53 Mutated, Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN)

James Rocco, MD, PhD – De-intensified Radiation Therapy with Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients with Early-stage, HPV-positive, Non-smoking Associated Oropharyngeal Cancer

Roman Skoracki, MD – Head and Neck Cancer Patient Symptoms and Oncologic Outcomes as a Function of Head and Neck Volume Changes

Brad deSilva, MD – Voice Outcomes Following Transcutaneous Steroid Injection for Vocal Fold Nodules Combined With Voice Therapy Compared to Voice Therapy Alone 

Emily Plowman, PhD – Dissemination and Implementation of DIGEST as an Evidence-based Measurement Tool in Cancer 

Emily Plowman, PhD – Establishing Reference Values and Clinical Decision Points of Swallowing

Emily Plowman, PhD – Mechanisms, Predictors and Detection of Dysphagia in Cardiac Surgical Patients 

Emily Plowman, PhD – Metformin: Effects on RAN Proteins, Breathing, Imaging, and Metabolomic Outcomes

Apoorva Ramaswamy, MD – Impact of Balloon Dilation on Swallowing Safety and Patient Reported Swallowing Function

Oliver Adunka, MD – Cochlear Implantation During Vestibular Schwannoma Removal or During Labyrinthectomy Surgery for Treatment of Meniere’s Disease 

Oliver Adunka, MD – Clinical Utility of Residual Hearing in the Cochlear Implant Ear

Oliver Adunka, MD – A Pivotal, Prospective, Multi-centre, Randomize Control, Blinded Study Evaluating the Efficacy of a Dexamethasone Eluting Slim Modiolar Electrode (CI632D) in the Reduction of Fribrosis as Compared to a Standard Slim Modiolar Electrode (CI632) in a Newly Implanted Adult Population with Bilateral, Post-linguistic, Moderate to Profound Sensorineural Hearing Loss

Oliver Adunka, MD – Expanded indications in the pediatric BoneBridge population

Ursula Findlen, PhD – A Natural History Study in Pediatric Participants With Hearing Loss Due to OTOF, GJB2, or GJB2/GJB6 Mutations

Shuman He, MD, PhD – Auditory Neural Function in Implanted Patients with Usher Syndrome

Kai Zhao, PhD – 3D Printing to Improve Nasal Irrigation Outcomes

Kai Zhao, PhD – Olfactory Training for Patients With Olfactory Losses

Kai Zhao, PhD – Sinonasal Visualization and Quantification of the Effect of Oxymetazoline Nasal Spray